Kezar Life Sciences, Inc. (KZR)
USD 6.29
(-3.53%)
USD 6.29
(-3.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -81.64 Million | -58.84 Million | -42.43 Million | -36.94 Million | -29.87 Million | -20.79 Million |
| Net Income | -101.87 Million | -68.23 Million | -54.63 Million | -41.74 Million | -35.08 Million | -23.16 Million |
| Depreciation & Amortization | 1.06 Million | 1.02 Million | 1.51 Million | 1.54 Million | 1.3 Million | 690 Thousand |
| Deferred income taxes | -6.34 Million | - | 1.77 Million | - | - | - |
| Stock-based compensation | 18.13 Million | 14 Million | 7.59 Million | 4.94 Million | 4 Million | 1.99 Million |
| Change in working capital | 4.7 Million | -4.45 Million | 1.22 Million | -2.01 Million | 881 Thousand | 62 Thousand |
| Other non-cash items | 2.66 Million | -1.17 Million | 91 Thousand | 317 Thousand | -979 Thousand | -370 Thousand |
| Investing Cash Flow | 76.04 Million | -91.39 Million | -28.44 Million | -56.49 Million | 20.41 Million | -83.9 Million |
| Investments in PPE | -1.81 Million | -1.57 Million | -316 Thousand | -194 Thousand | -607 Thousand | -1.12 Million |
| Acquisitions | 5000.00 | 89.81 Thousand | 28.12 Thousand | 56.3 Thousand | -21.02 Thousand | 10 Thousand |
| Investment purchases | -180.39 Million | -332.2 Million | -156.37 Million | -225.72 Million | -102.25 Million | -119.24 Million |
| Sales/Maturities of investments | 258.25 Million | 242.38 Million | 128.25 Million | 169.42 Million | 123.28 Million | 36.45 Million |
| Other Investing Activities | 77.85 Million | -89.81 Thousand | -28.12 Thousand | -56.3 Thousand | 21.02 Thousand | 10 Thousand |
| Financing Cash Flow | 638 Thousand | 127.86 Million | 112.58 Million | 99.64 Million | 272 Thousand | 77.91 Million |
| Debt repayment | - | - | -9.53 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 638 Thousand | 127.86 Million | 103.05 Million | 99.64 Million | 272 Thousand | 77.69 Million |
| Other Financing Activities | 638 Thousand | 127.86 Million | 19.06 Million | 99.64 Million | 272 Thousand | 218 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 6.34 Million | 1.81 Million | 1.21 Million | 313 Thousand | 2.2 Million | 1.44 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.64 Million | -6.27 Million | 9000.00 | -2.32 Million | -1.32 Million | -1.37 Million |
| Cash at beginning of period | 40.45 Million | 62.88 Million | 21.22 Million | 14.95 Million | 24.18 Million | 51.04 Million |
| Cash at end of period | 35.49 Million | 40.45 Million | 62.88 Million | 21.22 Million | 14.95 Million | 24.18 Million |
| Capital Expenditure | -1.81 Million | -1.57 Million | -316 Thousand | -194 Thousand | -607 Thousand | -1.12 Million |
| Effect of forex changes on cash | -2000.00 | -49 Thousand | -50 Thousand | 82 Thousand | -45 Thousand | -81 Thousand |
| Net cash flow / Change in cash | -4.96 Million | -22.42 Million | 41.65 Million | 6.27 Million | -9.23 Million | -26.86 Million |
| Free Cash Flow | -83.45 Million | -60.42 Million | -42.75 Million | -37.14 Million | -30.48 Million | -21.91 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -21.54 Million | -21.65 Million | -32.25 Million | -101.87 Million | -23.1 Million | -24.3 Million |
| Depreciation & Amortization | 261 Thousand | 260 Thousand | 280 Thousand | 1.06 Million | 278 Thousand | 249 Thousand |
| Deferred income taxes | - | - | -2.82 Million | -6.34 Million | -1.76 Million | -1.81 Million |
| Stock-based compensation | 3.08 Million | 3.43 Million | 3.22 Million | 18.13 Million | 6.63 Million | 4.02 Million |
| Change in working capital | 945 Thousand | -3.44 Million | 8.34 Million | 4.7 Million | -2.3 Million | 199 Thousand |
| Other non-cash items | 3.92 Million | 5.51 Million | 4.25 Million | 2.66 Million | 58 Thousand | 59 Thousand |
| Investing Cash Flow | 12.21 Million | 20.4 Million | 27.87 Million | 76.04 Million | 18.57 Million | 13.2 Million |
| Investments in PPE | - | - | -1000.00 | -1.81 Million | -136 Thousand | -1.37 Million |
| Acquisitions | - | - | 26.26 Thousand | 5000.00 | 5000.00 | -14.57 Thousand |
| Investment purchases | -34.78 Million | -17.34 Million | -49.87 Million | -180.39 Million | -35.29 Million | -41.17 Million |
| Sales/Maturities of investments | 47 Million | 37.75 Million | 77.75 Million | 258.25 Million | 54 Million | 55.75 Million |
| Other Investing Activities | - | 20.4 Million | 27.87 Million | 77.85 Million | 18.71 Million | 14.57 Thousand |
| Financing Cash Flow | 56 Thousand | - | 59 Thousand | 638 Thousand | 43 Thousand | 382 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 56 Thousand | - | 59 Thousand | 638 Thousand | 43 Thousand | 382 Thousand |
| Other Financing Activities | - | - | 59 Thousand | 638 Thousand | 43 Thousand | 382 Thousand |
| Accounts receivables | - | - | 7 Million | - | -7 Million | - |
| Accounts payables | -97 Thousand | -3 Million | 959 Thousand | 6.34 Million | 2.93 Million | 1.1 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.04 Million | -440 Thousand | 7.38 Million | -1.64 Million | -5.24 Million | -901 Thousand |
| Cash at beginning of period | 33.03 Million | 35.49 Million | 26.49 Million | 40.45 Million | 28.1 Million | 36.12 Million |
| Cash at end of period | 28.27 Million | 33.03 Million | 35.49 Million | 35.49 Million | 26.49 Million | 28.1 Million |
| Capital Expenditure | - | - | -1000.00 | -1.81 Million | -136 Thousand | -1.37 Million |
| Effect of forex changes on cash | 3000.00 | -7000.00 | 38 Thousand | -2000.00 | -23 Thousand | -5000.00 |
| Net cash flow / Change in cash | -4.75 Million | -2.46 Million | 8.99 Million | -4.96 Million | -1.61 Million | -8.02 Million |
| Free Cash Flow | -17.03 Million | -22.86 Million | -18.98 Million | -83.45 Million | -20.34 Million | -22.97 Million |
PESI
FILATEX
NSC
MOTILALOFS
BVGG
AGS